Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction Between Nevirapine and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women
NCT02182791Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1998
- Primary completion
- Apr 1999
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the plasma concentration time curve at Day 30, Maximum observed concentration at Day 30 and 4 more. Started Apr 1998; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02182791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182791.